SCHEMBL6025142

SCHEMBL6025142

CCCCCCC=CCCCCCC(CCCCC)NC(=O)OCC(C)(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A5 Q9Y345 1/20 0.41
CTSK P43235 1/20 0.41
FAAH O00519 3/20 0.40
FFAR1 O14842 1/20 0.40
FFAR4 Q5NUL3 1/20 0.40
EPHX2 P34913 2/20 0.40
DEGS1 O15121 1/20 0.40
GMNN O75496 1/20 0.40
USP2 O75604 1/20 0.40
LMNA P02545 1/20 0.40
CYP1A2 P05177 1/20 0.40
POLB P06746 1/20 0.40
MAPT P10636 1/20 0.40
CYP2C9 P11712 1/20 0.40
ALOX15 P16050 1/20 0.40
APEX1 P27695 1/20 0.40
CYP2C19 P33261 1/20 0.40
RECQL P46063 1/20 0.40
BLM P54132 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6025137 1.00 SLC6A5 (0.41) SLC6A5CTSKFAAHFFAR1FFAR4
SCHEMBL5694900 0.86 FAAH (0.51) SLC6A5FAAHGMNNUSP2LMNA
SCHEMBL1941195 0.83 CTSK (0.46) CTSKCYP1A2MAPTCYP2C9CYP2C19
SCHEMBL1941197 0.83 CTSK (0.46) CTSKCYP1A2MAPTCYP2C9CYP2C19
SCHEMBL4551745 0.83 TERT (0.46) SLC6A5FAAHFFAR1FFAR4GMNN
SCHEMBL4551744 0.83 TERT (0.46) SLC6A5FAAHFFAR1FFAR4GMNN
SCHEMBL1942212 0.81 EPHX2 (0.45) SLC6A5FAAHEPHX2
SCHEMBL19139428 0.81 MGLL (0.47) FFAR1FFAR4LMNAALOX15HSD17B10
SCHEMBL1942211 0.81 EPHX2 (0.45) SLC6A5FAAHEPHX2
SCHEMBL14848244 0.79 MGLL (0.58)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1629000-A4 MACROCYCLIC ISOQUINOLINE PEPTIDE INHIBITORS OF HEPATITIS C VIRUS BRISTOL MYERS SQUIBB CO (US) 2006-11-29 EP disclosed
EP-1629000-A2 MACROCYCLIC ISOQUINOLINE PEPTIDE INHIBITORS OF HEPATITIS C VIRUS Bristol-Myers Squibb Company (US) 2006-03-01 EP disclosed
WO-2004094452-A2 MACROCYCLIC ISOQUINOLINE PEPTIDE INHIBITORS OF HEPATITIS C VIRUS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-11-04 WO disclosed